Organization
Incyte Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Incyte Corp.
... Immuno-oncology company Agenus Inc (NASDAQ:AGEN) on Monday announced that Incyte has made a cash milestone payment of USD5m for the initiation of ...
... and adoptive cell therapies1, announced today receipt of a cash milestone from Incyte for the initiation of a Phase 1 clinical trial of INCAGN2385, an ...
... Incyte Corporation (NASDAQ:INCY) and Foundation Medicine, Inc., today announced that the companies have entered ...
... drug back in 2012 and hoped it could be a rival to Incyte's Jakafi, which works in a similar way. But trial flops two years ...
... with an initial focus on metastatic colorectal cancer. Through its collaboration with Incyte Corporation, Merus is also developing a preclinical bispecific antibody designed to bind ...
... is being developed as part of a collaboration and license agreement with Incyte. Advanced Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis. Arginase has ...
... Group Holdings, L.P. (NYSE:PAGP), The Hain Celestial Group, Inc. (NASDAQ:HAIN), and Incyte Corporation (NASDAQ:INCY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst ...
... first-in-class bispecifics. We have delivered on our partnership commitments with Merck and Incyte with 2 programs in the clinic this year and a third expected ...
... has reached two important milestones in its ongoing clinical trial collaboration with Incyte Corporation. Investigators have completed enrollment for both Phase 1b dosing cohorts and ...
... the DECIDE1 trial in Ovarian CancerAdvanced Ongoing Clinical Programs with Merck and Incyte HALIFAX, Nova Scotia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq:IMV) ...
Subscribe now for full coverage on Incyte Corp.
Start My Free Trial